Clene
Develops CNM-Au8, an investigational oral therapy for ALS and multiple sclerosis.
$4.23
After-hours close−0.05 (−1.17%)
At close$4.28(−4.25%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.46 | — | — |
| Aug 2026 | −$0.37 | −$1.08 | −193.5% |
| May 2026 | −$0.50 | −$0.31 | +38.0% |
| Mar 2026 | −$0.74 | −$0.88 | −18.9% |
| Nov 2025 | −$0.60 | −$0.85 | −41.7% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.46 | — | — | $70.0K | — | — |
| Aug 14, 2026 | −$0.37 | −$1.08 | −193.5% | $61.0K | $90.0K | +47.5% |
| May 14, 2026 | −$0.50 | −$0.31 | +38.0% | $50.8K | $15.0K | −70.4% |
| Mar 12, 2026 | −$0.74 | −$0.88 | −18.9% | $26.0K | $77.0K | +196.2% |
| Nov 13, 2025 | −$0.60 | −$0.85 | −41.7% | $64.3K | $15.0K | −76.7% |
The latest year is open to everyone — the 26 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 24, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 13, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 12, 2023 | ||||||
| Mar 13, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 15, 2022 | ||||||
| May 9, 2022 | ||||||
| Mar 11, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 11, 2021 | ||||||
| Mar 29, 2021 | ||||||
| Dec 18, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||